Loading...
IDEAYA Biosciences, Inc.
IDYA•NASDAQ
Healthcare
Biotechnology
$24.50
$-0.33(-1.33%)
IDEAYA Biosciences, Inc. (IDYA) Financial Performance & Income Statement Overview
Review IDEAYA Biosciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-70.07%
↓ 70.07%
Operating Income Growth
-143.23%
↓ 143.23%
Net Income Growth
-142.98%
↓ 142.98%
Operating Cash Flow Growth
-114.87%
↓ 114.87%
Operating Margin
-5147.81%
↓ 5147.81%
Gross Margin
75.14%
↑ 75.14%
Net Profit Margin
-4375.86%
↓ 4375.86%
ROE
-29.20%
↓ 29.20%
ROIC
-34.33%
↓ 34.33%
IDEAYA Biosciences, Inc. (IDYA) Income Statement & Financial Overview
Review IDEAYA Biosciences, Inc.'s (IDYA) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $7.00M | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $1.10M | $1.08M |
| Gross Profit | $7.00M | $0.00 | -$1.10M | -$1.08M |
| Gross Profit Ratio | $1.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $140.18M | $57.15M | $54.53M | $42.80M |
| SG&A Expenses | $10.96M | $9.74M | $9.30M | $8.21M |
| Operating Expenses | $151.14M | $66.89M | $63.83M | $51.02M |
| Total Costs & Expenses | $151.14M | $66.89M | $64.93M | $51.02M |
| Interest Income | $13.83M | $15.07M | $12.15M | $11.45M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $643000.00 | $1.01M | $1.10M | $1.08M |
| EBITDA | -$143.50M | -$66.89M | -$64.31M | -$50.40M |
| EBITDA Ratio | -$20.50 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$144.14M | -$66.89M | -$64.93M | -$51.02M |
| Operating Income Ratio | -$20.59 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $13.83M | $15.07M | $12.15M | $11.45M |
| Income Before Tax | -$130.31M | -$51.82M | -$52.77M | -$39.57M |
| Income Before Tax Ratio | -$18.62 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$1.08M |
| Net Income | -$130.31M | -$51.82M | -$52.77M | -$39.57M |
| Net Income Ratio | -$18.62 | $0.00 | $0.00 | $0.00 |
| EPS | -$1.60 | -$0.60 | -$0.68 | -$0.53 |
| Diluted EPS | -$1.60 | -$0.60 | -$0.68 | -$0.53 |
| Weighted Avg Shares Outstanding | $81.68M | $86.19M | $77.96M | $75.11M |
| Weighted Avg Shares Outstanding (Diluted) | $81.68M | $86.19M | $77.96M | $75.11M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan